Company Overview and News
Recently, Sabra Health Care REIT (SBRA - Free Report) announced the selling of nine healthcare facilities leased to Genesis Healthcare (GEN - Free Report) on Jun 29, in a bid to dispose the properties leased to the latter. These healthcare facilities have been sold for $81.4 million.
CXP PSB SBRA PSB.PRV ADI PSB.PRW PSB.PRX PSB.PRY GEN PSB.PRS PSB.PRT PSB.PRU SBRAP
IRVINE, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Sabra Health Care REIT, Inc. (Nasdaq:SBRA) announced today that on June 29, 2018, it completed the previously announced sale of nine facilities (seven skilled nursing facilities, one senior housing community and one continuing care retirement community) leased to Genesis Healthcare, Inc. (“Genesis”) for $81.4 million. Under the terms of Sabra’s memoranda of understanding with Genesis, Genesis’s annual rent obligations to Sabra were reduced by $7.
GEN CCP SBRA SBRAP
Here we are with another installment of my "stock considerations" for the upcoming month. With the first week of trading upon us in July, it is time, once again, to lay out a plan for my potential stock pick(s) for the month. As many of you already know, I make sure to purchase at least one stock every single month, no matter where we are in a business or macroeconomic cycle. The goal of every long-term dividend growth investor is to remain consistent with their buys and try not to attempt to time the market and wait for the "best" possible time to invest.
SOJA HCN PM GIS HCP WELL.PRI LTC SBRA WELL CAH ED JCI SBRAP VTR SO GE GEC D HCN.PRJ KMB HCN.PRI PEP KHC GNE SBUX CLX
Investing solely for income, and finding the best dividend stocks, can be tricky. High dividend yields sound attractive on the surface, but almost always come with sharply higher risks. The largest risk is that the very same dividend will be cut. Those cuts usually have a doubled impact. They reduce — or eliminate — the income stream investors were buying in the first place. And as shareholders in companies like General Electric (NYSE:GE), Frontier Communications (NASDAQ:FTR) and Mattel (NASDAQ:MAT) have learned, they often coincide with steep declines in the share price as well.
GIS PG GOOG SBRA AMZN FTRPR GM.WS.A GM.WS.B GM.WS.C GM CVA SBRAP GE F GEC UPS WYNN FDX NYTAB MAT GOOGL TSLA GNE LVS GM.WSB FTR
IRVINE, Calif., June 15, 2018 (GLOBE NEWSWIRE) -- Sabra Health Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP) announced today that Harold Andrews, the company’s Chief Financial Officer will be participating in the JMP Securities Boston Real Estate Forum being held June 28th at The Langham in Boston, MA.
We’ll look at some successes, failures, and curious bifurcations that split off the ugly ducklings from the magnificent SWANs.
VTR DDR UE.WI GRT.PRH GRT.PRG UE SBRA 511768 DDR.PRJ SPG.PRJ JBGS DDR.PRK MASTERTR DDR.PRA SPG SMTA CCP SBRAP
IRVINE, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Sabra Health Care REIT, Inc. (Nasdaq:SBRA) announced today that on June 1, 2018, it completed the previously announced sale of 12 facilities (11 skilled nursing facilities and 1 senior housing community) leased to Genesis Healthcare, Inc. (“Genesis”) located in New Hampshire and Florida for $134.0 million. Under the terms of Sabra’s memoranda of understanding with Genesis, Genesis’s annual rent obligations to Sabra were reduced by $12.
GEN CCP SBRA SBRAP
This article is Update 29 (and the last) to my original article entitled "If I Had to Build An Income Portfolio Today".
GEO UNIT STAG.PRB STAG.PRC EPD TD SBRA STWD.WI VZA CALM WELL STAG TD HASI STAG.PRA SBRAP VTR DOC PEGI RY TNTTF VDE IRM RY ORI CLDT WES PEG VZ STWD OHI
IRVINE, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Sabra Heath Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP) (“Sabra”, “we” or the “Company”) announced today that it has entered into definitive agreements to restructure the Company’s master leases with its tenant, Signature HealthCARE (“Signature”), including the provision to Signature of working capital in the form of a term loan.
GEN OHI CCP SBRA SBRAP
Apartment Investment & Management Co. (AIV - Free Report) — commonly known as Aimco — is slated to report first-quarter 2018 results on May 7, after the market closes. While funds from operations (FFO) per share will likely increase on a year-over-year basis, revenues are expected to decline. In the last reported quarter, this Denver, CO-based residential real estate investment trust (REIT) met the Zacks Consensus Estimate for FFO.
WFC WFCNP WFC.WS HCP WFC.PRL WFC.PRJ RP SBRA WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN WFC.PRY WFC.PRX WFC.PRW WFC.PRV SBRAP
IRVINE, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- Sabra Health Care REIT, Inc. (Nasdaq:SBRA) (Nasdaq:SBRAP) (the “Company”) announced today that it will redeem all 5,750,000 outstanding shares of its 7.125% Series A Cumulative Redeemable Preferred Stock (the “Series A Preferred Stock”) (CUSIP: 78573L205) on June 1, 2018 (the “Redemption Date”). The shares of Series A Preferred Stock will be redeemed at a redemption price of $25.
9h - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
2018-07-13 - Asif
Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...
2018-07-09 - Asif
Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...
as of ET